AACR Cancer Disparities Report 2024: Breast Cancer
Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report.
Although there has been major progress against cancer in the United States, racial and ethnic minority groups are still diagnosed and treated at unequal levels when compared with White populations, according to a new report released May 15, 2024, from the American Association for Cancer Research (AACR), a professional organization for oncologists.
For example, cancer death rates have narrowed between Black and White populations. In 1990, that gap was 33% and in 2020, it had dropped to 11.3%. These inequalities also extend to breast cancer, the highlights of which are listed below.
Healthcare inequalities stem from a long history of structural prejudice and ongoing discrimination. As a result, many people in minority groups do not have the money or access to healthcare services. Unfavorable and stressful conditions can also lead to behaviors such as smoking or alcohol use which are major cancer risk factors.
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
